GE Gains Sleep Apnea, Anesthesia Products In $860 Mil. Vital Signs Purchase

GE Healthcare's $860 million acquisition of Vital Signs Inc. provides an entry into the rapidly growing sleep apnea market and complementary offerings for its anesthesia and broader respiratory care businesses